Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Nicox signs agreement for NCX 4251 in China with Ocumension Therapeutics for up to €12 million in milestones plus royalties

July 2, 2019

View Press Release Corporate presentation Contact us
Previous